Zika Virus Infection and Immune Response
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Molecular Microbiology and Immunology".
Deadline for manuscript submissions: 15 October 2024 | Viewed by 769
Special Issue Editors
Interests: viral pathogenesis; vertical transmission; virus–host interaction; host immunity
Special Issue Information
Dear Colleagues,
Zika virus (ZIKV) is an emerging mosquito-borne flavivirus that can cause serious illness, including congenital birth defects and Guillain–Barré syndrome during pregnancy. Up until now, there are no licensed effective vaccines or curative antiviral drugs available to treat Zika virus in humans. In immunocompetent adults, Zika virus causes subclinical manifestations with mild symptoms that usually resolve rapidly. However, infections during pregnancy can have devastating effects on the fetus, particularly microcephaly, craniofacial abnormalities, muscle and joint developmental defects, fetal death, and audiovisual abnormalities.
For this Special Issue, we welcome research on the latest findings on ZIKV infection, including, but not limited to the following areas:
- sexual transmission;
- innate immunity in skin and reproductive organs;
- molecular pathways impacting ZIKV replication and interferon responses;
- Zika virus infection in pregnancy, virus transmission across the placental and blood–brain barrier, and host immunity during pregnancy, especially at the maternal–fetal interface;
- interactions between the virus and brain cells;
- cross-reactive immunity and antibody-mediated enhancement of infection;
- therapeutic and prophylactic interventions of viral infection;
- interventions of disease progression;
- vaccination during pregnancy.
The aim of this Special issue is to provide a broad overview of current research on ZIKV and the host immune response from molecular to cellular features, which will help to develop better control of viral infection and clinical interventions.
As Guest Editors of the Special Issue, we cordially invite you to participate. We encourage authors to submit original research articles, review articles, and short communications related to the topic.
Dr. In-Jeong Kim
Dr. Shelton Bradrick
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at mdpi.longhoe.net by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Zika virus
- virus transmission
- immunopathogenesis
- innate and adaptive immunity
- cross-reactive immunity
- cross-reactivity
- pregnancy
- neurodevelopment
- vaccine
- antivirals
